We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

149 hedge funds and large institutions have $279M invested in Filana Therapeutics in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 51 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less call options, than puts

Call options by funds: $106M | Put options by funds: $109M

1.36% less ownership

Funds ownership: 26.25% → 24.89% (-1.4%)

9% less funds holding

Funds holding: 163 → 149 (-14)

24% less repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 51

28% less capital invested

Capital invested by funds: $390M → $279M (-$111M)

43% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 28

Holders
149
Holders Change
-14
Holders Change %
-8.59%
% of All Funds
2.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
39
Reduced
51
Closed
28
Calls
$106M
Puts
$109M
Net Calls
-$2.45M
Net Calls Change
+$65.4M

Top Buyers

Rank Fund Capital Flow
1
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$5.5M
2
Bank of America
Bank of America
North Carolina
+$2.85M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.84M
4
Morgan Stanley
Morgan Stanley
New York
+$1.74M
5
JG
Jefferies Group
New York
+$1.49M

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$5.18M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$4.47M
3
National Bank of Canada
National Bank of Canada
Quebec, Canada
-$2.98M
4
RCMNY
Rubric Capital Management (New York)
New York
-$2.58M
5
Principal Financial Group
Principal Financial Group
Iowa
-$2.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
IWA
51
IVC Wealth Advisors
Pennsylvania
$405K +$3.16K +125 +0.9%
Cambridge Investment Research Advisors
52
Cambridge Investment Research Advisors
Iowa
$388K -$52.8K -2,091 -13%
Baird Financial Group
53
Baird Financial Group
Wisconsin
$385K -$9.24K -366 -3%
Commonwealth Equity Services
54
Commonwealth Equity Services
Massachusetts
$383K +$18.7K +739 +6%
Simplex Trading
55
Simplex Trading
Illinois
$373K +$183K +7,235 +120%
EL
56
Essex LLC
Illinois
$352K +$11.8K +467 +4%
Creative Planning
57
Creative Planning
Kansas
$349K -$58.9K -2,333 -16%
CAN
58
Cetera Advisor Networks
California
$330K -$334K -13,242 -53%
Mirae Asset Global Investments
59
Mirae Asset Global Investments
South Korea
$325K +$292K +11,545 New
Ensign Peak Advisors
60
Ensign Peak Advisors
Utah
$316K – – –
LIM
61
Leavell Investment Management
Alabama
$315K +$283K +11,200 New
Principal Financial Group
62
Principal Financial Group
Iowa
$292K -$2.3M -90,948 -90%
ASRS
63
Arizona State Retirement System
Arizona
$290K +$657 +26 +0.3%
IMC Chicago
64
IMC Chicago
Illinois
$285K +$256K +10,132 New
Handelsbanken Fonder
65
Handelsbanken Fonder
Sweden
$281K -$5.05K -200 -2%
CG
66
Cutler Group
California
$280K +$19.2K +760 +8%
TRCT
67
Tower Research Capital (TRC)
New York
$278K +$190K +7,531 +317%
Victory Capital Management
68
Victory Capital Management
Texas
$274K -$111K -4,395 -31%
Envestnet Asset Management
69
Envestnet Asset Management
Illinois
$273K +$75.3K +2,981 +44%
HF
70
HRT Financial
New York
$270K +$243K +9,630 New
Citadel Advisors
71
Citadel Advisors
Florida
$266K +$239K +9,449 New
RJFSA
72
Raymond James Financial Services Advisors
Florida
$261K -$67.3K -2,665 -22%
AWM
73
Apollon Wealth Management
South Carolina
$257K +$1.97K +78 +0.9%
Rafferty Asset Management
74
Rafferty Asset Management
New York
$242K -$89.3K -3,538 -29%
Janus Henderson Group
75
Janus Henderson Group
United Kingdom
$212K +$25 +1 +0%
1 2
3
4 5

FLNA Hedge Fund Activity: Q2 2022 in Review

149 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q2 2022, worth a combined $279M — down 28% from $390M a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of FLNA and 16 opened new positions — a net loss of 12 holders — while 51 trimmed existing stakes and 39 added.

The largest buyer was BNP Paribas Financial Markets, adding an estimated $5.5M. The largest seller was Group One Trading, cutting an estimated $5.18M.

  • 149 institutional investors held Filana Therapeutics (FLNA) as of Q2 2022, down from 163 in Q1 2022.
  • Funds reported $279M of Filana Therapeutics stock for Q2 2022, down 28% quarter-over-quarter.
  • 16 funds opened new Filana Therapeutics positions in Q2 2022 and 28 closed out, a net change of -12 holders.
  • The largest Filana Therapeutics buyer in Q2 2022 was BNP Paribas Financial Markets, an estimated $5.5M added.
  • The largest Filana Therapeutics seller in Q2 2022 was Group One Trading, an estimated $5.18M sold.

Based on aggregated 13F filings for Q2 2022.